population and nearly 19% percent of adults aged 75 years and older, according to data from a National Health and Wellness Survey.
“Restasis has been approved for use in the U.S.
Notably, Restasis’s developers attempted to keep its patents from federal review by transferring them to a Native American tribe in 2017 in the hopes of keeping other companies from creating lower-cost versions of the drug, Reuters reported.
All Rights Reserved This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.